As of Jul 02
| +0.14 / +0.26%|
The 2 analysts offering 12-month price forecasts for Cantel Medical Corp have a median target of 54.50, with a high estimate of 60.00 and a low estimate of 49.00. The median estimate represents a +1.66% increase from the last price of 53.61.
The current consensus among 2 polled investment analysts is to Buy stock in Cantel Medical Corp. This rating has held steady since June, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.